Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana
Abstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Nursing Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/nop2.1438 |
_version_ | 1811166932455391232 |
---|---|
author | Edem Kojo Dzantor Mubarick Nungbaso Asumah Abdul‐Wahab Inusah Nimota Ruth Nukpezah Yaa Nyarko Agyeman Margaret Wekem Kukeba Baba Abubakari Braimah Theophilus Adjeso Mohammed Mutaru Tahiru |
author_facet | Edem Kojo Dzantor Mubarick Nungbaso Asumah Abdul‐Wahab Inusah Nimota Ruth Nukpezah Yaa Nyarko Agyeman Margaret Wekem Kukeba Baba Abubakari Braimah Theophilus Adjeso Mohammed Mutaru Tahiru |
author_sort | Edem Kojo Dzantor |
collection | DOAJ |
description | Abstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25. Results The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self‐reported prevalence of SARS‐CoV‐2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self‐reported SARS‐CoV‐2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health‐targeted interventions to boost public confidence in SARS‐CoV‐2 vaccines. |
first_indexed | 2024-04-10T16:01:41Z |
format | Article |
id | doaj.art-a23ac9788af545fe90065582ea170c09 |
institution | Directory Open Access Journal |
issn | 2054-1058 |
language | English |
last_indexed | 2024-04-10T16:01:41Z |
publishDate | 2023-03-01 |
publisher | Wiley |
record_format | Article |
series | Nursing Open |
spelling | doaj.art-a23ac9788af545fe90065582ea170c092023-02-10T12:27:02ZengWileyNursing Open2054-10582023-03-011031785179310.1002/nop2.1438Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of GhanaEdem Kojo Dzantor0Mubarick Nungbaso Asumah1Abdul‐Wahab Inusah2Nimota Ruth Nukpezah3Yaa Nyarko Agyeman4Margaret Wekem Kukeba5Baba Abubakari Braimah6Theophilus Adjeso7Mohammed Mutaru Tahiru8Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health University of Health and Allied Sciences Hohoe GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Preventive Nursing School of Nursing and Midwifery, University for Development Studies Tamale GhanaDepartment of Population and Reproductive Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Nursing School of Nursing and Midwifery, CKT‐University of Technology and Applied Sciences Navrongo GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaDepartment of Ear Nose and Throat, School of Medicine University for Development Studies Tamale GhanaDepartment of Global/International Health School of Public Health, University for Development Studies Tamale GhanaAbstract Aim The study examined the associated adverse events following SARS‐CoV‐2 vaccination among healthcare workers during the first dose of the vaccine in the Northern Region of Ghana. Design The study was a cross‐sectional survey involving 463 healthcare workers. Method The data were collected using a structured questionnaire. The data were analysed descriptively, and binary logistics was performed using SPSS version 25. Results The mean age was 33.4 ± 9.7 years, the majority (43.6%) being ≤30 years and males (57.2%). The self‐reported prevalence of SARS‐CoV‐2 vaccine adverse events was 75.5%. Common systemic adverse events comprised headache (47.5%), dizziness (18.4%) and local adverse events included generalized body pains (44.0%) and abscess around the injection sites (11.2%). The study found a high prevalence of self‐reported SARS‐CoV‐2 vaccine adverse events involving both systemic and local adverse events. Our study gives useful information that can be used for public health‐targeted interventions to boost public confidence in SARS‐CoV‐2 vaccines.https://doi.org/10.1002/nop2.1438adverse eventsfirst dosehealthcare workersSARS‐CoV‐2vaccine |
spellingShingle | Edem Kojo Dzantor Mubarick Nungbaso Asumah Abdul‐Wahab Inusah Nimota Ruth Nukpezah Yaa Nyarko Agyeman Margaret Wekem Kukeba Baba Abubakari Braimah Theophilus Adjeso Mohammed Mutaru Tahiru Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana Nursing Open adverse events first dose healthcare workers SARS‐CoV‐2 vaccine |
title | Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana |
title_full | Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana |
title_fullStr | Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana |
title_full_unstemmed | Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana |
title_short | Adverse events reported after first dose of SARS‐CoV‐2 vaccine in the Northern Region of Ghana |
title_sort | adverse events reported after first dose of sars cov 2 vaccine in the northern region of ghana |
topic | adverse events first dose healthcare workers SARS‐CoV‐2 vaccine |
url | https://doi.org/10.1002/nop2.1438 |
work_keys_str_mv | AT edemkojodzantor adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT mubaricknungbasoasumah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT abdulwahabinusah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT nimotaruthnukpezah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT yaanyarkoagyeman adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT margaretwekemkukeba adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT babaabubakaribraimah adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT theophilusadjeso adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana AT mohammedmutarutahiru adverseeventsreportedafterfirstdoseofsarscov2vaccineinthenorthernregionofghana |